Amy DiCamillo

Corporate Officer/Principal bij Melior Discovery, Inc.

Commercial Services

Consumer Services

Actieve functies van Amy DiCamillo

Bedrijven	Functie	Begin	Einde
Melior Discovery, Inc. Melior Discovery, Inc. Miscellaneous Commercial ServicesCommercial Services Melior Discovery, Inc. provides phenotypic screening, in vivo pharmacology, drug abuse liability and seizure potential services. It offers theraTRACE, an indications discovery platform of multiplexed in vivo models that focus on various indications/therapeutic areas, including neurodegenerative disease and psychiatry, inflammation, acute and chronic pain, metabolic disease, gastrointestinal & urology, cardiovascular disease, and dermatology aspects. The company was founded by Andrew G. Reaume and Michael S. Saporito in 2005 and is headquartered in Exton, PA.	Corporate Officer/Principal	-	-
	Hoofd Techniek/Wetenschap/O&O	-	-

West Chester University of Pennsylvania

Graduate Degree

Internationaal

Verenigde Staten

Operationeel

Chief Tech/Sci/R&D Officer	1
Corporate Officer/Principal	1
Graduate Degree	1

Sectoraal

Commercial Services	2
Consumer Services	2

Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Bedrijven in privébezit	1
Melior Discovery, Inc. Melior Discovery, Inc. Miscellaneous Commercial ServicesCommercial Services Melior Discovery, Inc. provides phenotypic screening, in vivo pharmacology, drug abuse liability and seizure potential services. It offers theraTRACE, an indications discovery platform of multiplexed in vivo models that focus on various indications/therapeutic areas, including neurodegenerative disease and psychiatry, inflammation, acute and chronic pain, metabolic disease, gastrointestinal & urology, cardiovascular disease, and dermatology aspects. The company was founded by Andrew G. Reaume and Michael S. Saporito in 2005 and is headquartered in Exton, PA.	Commercial Services

Bedrijven in privébezit

Commercial Services